Cormorant Private Healthcare Fund III LP
Related Filers (21)
- Chen Bihua (40)
- Cormorant Global Healthcare Master Fund, LP (40)
- Cormorant Asset Management, LP (40)
- Cormorant Private Healthcare Fund II, LP (10)
- Biomea Fusion, Inc. (6)
- Ambrx Biopharma Inc. (5)
- Prometheus Biosciences, Inc. (3)
- Immuneering Corp (3)
- Olema Pharmaceuticals, Inc. (2)
- Design Therapeutics, Inc. (2)
- Rain Therapeutics Inc. (2)
- Verve Therapeutics, Inc. (2)
- Monte Rosa Therapeutics, Inc. (2)
- Elevation Oncology, Inc. (2)
- Icosavax, Inc. (2)
- Tyra Biosciences, Inc. (2)
- Pyxis Oncology, Inc. (2)
- Ventyx Biosciences, Inc. (2)
- Cormorant Private Healthcare Fund IV LP (2)
- MoonLake Immunotherapeutics (2)
- Ambrx Biopharma, Inc. (1)
- Show More ...
Other (2)
D/A
Wednesday, 6/16/2021
Exempt (Private) Offering
D
Tuesday, 7/14/2020
Exempt (Private) Offering
Ownership (40)
4
Wednesday, 10/25/2023
Ambrx Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/19/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 4/24/2023
Immuneering Corp: Initial statement of beneficial ownership of securities
4
Thursday, 4/20/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/17/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/16/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 3/13/2023
Ambrx Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/24/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/27/2021
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/20/2021
Ventyx Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 10/15/2021
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/7/2021
Pyxis Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/21/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
Tyra Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/5/2021
Immuneering Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/4/2021
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Immuneering Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 7/28/2021
Icosavax, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/1/2021
Elevation Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/24/2021
Elevation Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Verve Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/16/2021
Verve Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/29/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/22/2021
Rain Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/22/2021
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/19/2021
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/15/2021
Biomea Fusion, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/1/2021
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Design Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3/A
Thursday, 3/18/2021
Prometheus Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 3/18/2021
Prometheus Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/11/2021
Prometheus Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/23/2020
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/18/2020
Olema Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities